Food News and Research

RSS

First Edition: November 6, 2013

Today's headlines include reports detailing the contents of the health law's "war room" notes as well as scene-setters for today's Senate hearing testimony about healthcare.gov by Health and Human Services Secretary Kathleen Sebelius.

6 Nov 2013

Wild blueberries: 2 cups a day may keep the doctor away

Wild blueberries are a rich source of phytochemicals called polyphenols, which have been reported by a growing number of studies to exert a wide array of protective health benefits. A new study by researchers at the University of Maine adds to this growing body of evidence.

6 Nov 2013

Johnson & Johnson to pay $2.2 billion fine to resolve drug marketing case

The government alleged that the drug company and its subsidiaries promoted psychiatric medications for uses that had not been approved by the Food and Drug Administration.

6 Nov 2013

FDA issues GRAS Letters of No Objection for Morinaga's proprietary probiotic strain

Morinaga Milk Industry Co., Ltd., the second largest dairy product company in Japan, today announced that the U.S. Food and Drug Administration has issued Generally Recognized as Safe Letters of No Objection for Morinaga's proprietary probiotic strain, Bifidobacterium breve M-16V for food applications and infant formulas.

6 Nov 2013

American Dryer unveils new product with Cold Plasma Clean technology

American Dryer recently unveiled a new product that incorporates cold plasma, a natural occurring phenomenon, into its market-leading hand dryers.

6 Nov 2013

Bioniche Life Sciences announces financial results for first quarter of Fiscal 2014

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of Fiscal 2014 (ended September 30, 2013).

6 Nov 2013

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.

6 Nov 2013

Aeterna Zentaris submits macimorelin acetate NDA to FDA

Aeterna Zentaris Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration ("FDA") for its ghrelin agonist, macimorelin acetate (AEZS-130).

5 Nov 2013

Weight loss surgery: The most effective weapon for obese people in the battle against diabetes

Noted bariatric surgeon Michael Feiz, M.D., F.A.C.S., believes that there's no time like American Diabetes Month to point out that weight loss surgery is the most effective weapon obese people have in the battle against diabetes.

5 Nov 2013

First Edition: November 5, 2013

Today's headlines include continuing coverage of the implementation issues that are plaguing the health law, as well as President Barack Obama's pledge to campaign for the overhaul's success.

5 Nov 2013

Trophos completes efficacy study of olesoxime in patients with Spinal Muscular Atrophy

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, has completed its efficacy study of olesoxime in the rare neurodegenerative condition Spinal Muscular Atrophy.

5 Nov 2013

Access to health care increases prescription opioid abuse

Researchers at Indiana University-Purdue University Indianapolis say one way to gauge the extent of prescription opioid pain reliever abuse in any Indiana county is to count the number of health care providers, particularly dentists and pharmacists.

5 Nov 2013

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Reviva Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the discovery and development of new, safer and highly effective therapies for chronic indications, announced today the successful completion of an End-of-Phase 2 meeting with the Food and Drug Administration for its lead, new investigational antipsychotic drug, RP5063.

5 Nov 2013

Janssen Pharmaceuticals to pay over $1.6 billion in drug misbranding case

On behalf of the U.S. Food and Drug Administration, the U.S. Department of Justice today announced a guilty plea agreement with Janssen Pharmaceuticals, Inc., of Titusville, N.J., and a $400 million criminal fine for introducing a misbranded drug, Risperdal (risperidone), into interstate commerce.

5 Nov 2013

First ever Cardiovascular Health Week kicks off in Brussels

The first ever Cardiovascular Health Week kicks off today in the European Parliament in Brussels. It will go on until 8 November 2013 with awareness-raising activities around the theme ‘Mind Your Heart – for a Heart Healthy Europe’.

5 Nov 2013

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

Boehringer Ingelheim today announced new data from its Phase III clinical trial programme, STARTVerso, which evaluates faldaprevir in combination with pegylated interferon and ribavirin (PegIFN/RBV).

5 Nov 2013

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a Prior Approval Supplement for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII.

4 Nov 2013

Researchers study quality, effectiveness and safety of generic drugs used to treat depression

Researchers at Washington University School of Medicine in St. Louis are studying the quality, effectiveness and safety of generic drugs used to treat depression.

4 Nov 2013

CHFA launches five-part guide to help Canadians make informed decisions about natural health

To celebrate Natural Health Products Week, the Canadian Health Food Association is launching a free, five-part guide aimed at helping Canadian families make informed decisions about natural health. The Canadian Family's Guide to Navigating Natural Health, was developed with nutritionist and author Lianne Phillipson-Webb.

4 Nov 2013

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

Covalon Technologies Ltd., an advanced medical technologies company, today announced that it has licensed its antimicrobial silicone adhesive technology to Molnlycke Heath Care.

4 Nov 2013

Food News and Research

First Edition: November 6, 2013

Wild blueberries: 2 cups a day may keep the doctor away

Johnson & Johnson to pay $2.2 billion fine to resolve drug marketing case

FDA issues GRAS Letters of No Objection for Morinaga's proprietary probiotic strain

American Dryer unveils new product with Cold Plasma Clean technology

Bioniche Life Sciences announces financial results for first quarter of Fiscal 2014

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

Aeterna Zentaris submits macimorelin acetate NDA to FDA

Weight loss surgery: The most effective weapon for obese people in the battle against diabetes

First Edition: November 5, 2013

Trophos completes efficacy study of olesoxime in patients with Spinal Muscular Atrophy

Access to health care increases prescription opioid abuse

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Janssen Pharmaceuticals to pay over $1.6 billion in drug misbranding case

First ever Cardiovascular Health Week kicks off in Brussels

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Researchers study quality, effectiveness and safety of generic drugs used to treat depression

CHFA launches five-part guide to help Canadians make informed decisions about natural health

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

Understanding cultivated meat and its global potential eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News